Literature DB >> 1351234

Factor VIII and factor IX inhibitors in haemophiliacs.

R Ljung, P Petrini, A C Lindgren, L Tengborn, I M Nilsson.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1351234

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with hemophilia A: descriptive meta-analysis of post-marketing study data.

Authors:  A Yoshioka; K Fukutake; J Takamatsu; A Shirahata
Journal:  Int J Hematol       Date:  2006-08       Impact factor: 2.490

2.  A cohort study of the usefulness of primary prophylaxis in patients with severe haemophilia A.

Authors:  Chiai Nagae; Atsuki Yamashita; Tomoko Ashikaga; Mika Mori; Mieko Akita; Kaoru Kitsukawa; Satoshi Yamazaki; Kimie Yoshikawa; Hitoshi Yamamoto; Masashi Taki
Journal:  Int J Hematol       Date:  2016-04-28       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.